The FDA has accepted for review a resubmission of the BLA for bevacizumab-vikg (ONS-5010) for the treatment of wet AMD.

Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.

For children with myopia, wearing spectacles with highly aspherical lenslets (HAL) reduces the rate of myopia progression and axial elongation.

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ...

Signs of visual fatigue among children with cerebral visual impairment correlate with the amount of clutter in the room.

The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.

HALT spectacle lenses can significantly reduce myopic progression independently from, or as a supplement to, low-dose atropine.

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Reductions in optic disc microvasculature are associated with visual field progression in patients with primary open-angle glaucoma.

Using regression analysis, the investigators found that the control of axial growth with ortho-K treatment was better in the summer than in the winter (β=-0.05; P <.001). They observed a similar ...